Wuhan Keqian Biology Co Ltd (688526) — Cash Flow-to-Debt Ratio
Wuhan Keqian Biology Co Ltd (688526) has a Cash Flow-to-Debt Ratio of 0.30x as of September 2025, meaning its operating cash flow of CN¥174.36 Million could theoretically repay 0% of its total liabilities (CN¥580.21 Million) in one year. See Wuhan Keqian Biology Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Wuhan Keqian Biology Co Ltd Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Wuhan Keqian Biology Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Wuhan Keqian Biology Co Ltd.
Annual Cash Flow-to-Debt Ratio for Wuhan Keqian Biology Co Ltd (2016–2024)
Year-by-year debt coverage analysis for Wuhan Keqian Biology Co Ltd. Check 688526 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.71x | CN¥392.68 Million | CN¥552.80 Million | ▲ +10.1% |
| 2023 | 0.65x | CN¥538.03 Million | CN¥833.59 Million | ▲ +35.8% |
| 2022 | 0.48x | CN¥423.71 Million | CN¥891.63 Million | ▼ -48.9% |
| 2021 | 0.93x | CN¥531.27 Million | CN¥571.41 Million | ▼ -6.5% |
| 2020 | 0.99x | CN¥400.14 Million | CN¥402.40 Million | ▲ +62.1% |
| 2019 | 0.61x | CN¥154.89 Million | CN¥252.48 Million | ▼ -38.4% |
| 2018 | 1.00x | CN¥351.83 Million | CN¥353.51 Million | ▼ -23.7% |
| 2017 | 1.30x | CN¥337.61 Million | CN¥258.86 Million | ▲ +5.8% |
| 2016 | 1.23x | CN¥220.69 Million | CN¥179.01 Million | — |